全文获取类型
收费全文 | 1874篇 |
免费 | 218篇 |
出版年
2021年 | 28篇 |
2018年 | 16篇 |
2016年 | 22篇 |
2015年 | 44篇 |
2014年 | 37篇 |
2013年 | 52篇 |
2012年 | 81篇 |
2011年 | 79篇 |
2010年 | 53篇 |
2009年 | 45篇 |
2008年 | 45篇 |
2007年 | 62篇 |
2006年 | 52篇 |
2005年 | 47篇 |
2004年 | 49篇 |
2003年 | 75篇 |
2002年 | 64篇 |
2001年 | 60篇 |
2000年 | 57篇 |
1999年 | 43篇 |
1997年 | 16篇 |
1996年 | 19篇 |
1995年 | 17篇 |
1994年 | 19篇 |
1993年 | 20篇 |
1992年 | 46篇 |
1991年 | 47篇 |
1990年 | 60篇 |
1989年 | 59篇 |
1988年 | 53篇 |
1987年 | 42篇 |
1986年 | 44篇 |
1985年 | 37篇 |
1984年 | 33篇 |
1983年 | 26篇 |
1982年 | 21篇 |
1981年 | 31篇 |
1980年 | 24篇 |
1979年 | 44篇 |
1978年 | 31篇 |
1977年 | 37篇 |
1976年 | 33篇 |
1975年 | 38篇 |
1974年 | 18篇 |
1973年 | 25篇 |
1972年 | 27篇 |
1971年 | 15篇 |
1970年 | 15篇 |
1967年 | 15篇 |
1966年 | 18篇 |
排序方式: 共有2092条查询结果,搜索用时 15 毫秒
121.
122.
123.
124.
125.
126.
James M. Flynn Monique N. O'Leary Christopher A. Zambataro Emmeline C. Academia Michael P. Presley Brittany J. Garrett Artem Zykovich Sean D. Mooney Randy Strong Clifford J. Rosen Pankaj Kapahi Michael D. Nelson Brian K. Kennedy Simon Melov 《Aging cell》2013,12(5):851-862
Rapamycin has been shown to extend lifespan in numerous model organisms including mice, with the most dramatic longevity effects reported in females. However, little is known about the functional ramifications of this longevity‐enhancing paradigm in mammalian tissues. We treated 24‐month‐old female C57BL/6J mice with rapamycin for 3 months and determined health outcomes via a variety of noninvasive measures of cardiovascular, skeletal, and metabolic health for individual mice. We determined that while rapamycin has mild transient metabolic effects, there are significant benefits to late‐life cardiovascular function with a reversal or attenuation of age‐related changes in the heart. RNA‐seq analysis of cardiac tissue after treatment indicated inflammatory, metabolic, and antihypertrophic expression changes in cardiac tissue as potential mechanisms mediating the functional improvement. Rapamycin treatment also resulted in beneficial behavioral, skeletal, and motor changes in these mice compared with those fed a control diet. From these findings, we propose that late‐life rapamycin therapy not only extends the lifespan of mammals, but also confers functional benefits to a number of tissues and mechanistically implicates an improvement in contractile function and antihypertrophic signaling in the aged heart with a reduction in age‐related inflammation. 相似文献
127.
128.
Pseudomonas aeruginosa is an opportunistic bacterial pathogen which is the leading cause of morbidity and mortality among cystic fibrosis patients. Although P. aeruginosa is primarily considered an extacellular pathogen, recent reports have demonstrated that throughout the course of infection the bacterium acquires the ability to enter and reside within host cells. Normally intracellular pathogens are cleared through a process called autophagy which sequesters and degrades portions of the cytosol, including invading bacteria. However the role of autophagy in host defense against P. aeruginosa in vivo remains unknown. Understanding the role of autophagy during P. aeruginosa infection is of particular importance as mutations leading to cystic fibrosis have recently been shown to cause a blockade in the autophagy pathway, which could increase susceptibility to infection. Here we demonstrate that P. aeruginosa induces autophagy in mast cells, which have been recognized as sentinels in the host defense against bacterial infection. We further demonstrate that inhibition of autophagy through pharmacological means or protein knockdown inhibits clearance of intracellular P. aeruginosa in vitro, while pharmacologic induction of autophagy significantly increased bacterial clearance. Finally we find that pharmacological manipulation of autophagy in vivo effectively regulates bacterial clearance of P. aeruginosa from the lung. Together our results demonstrate that autophagy is required for an effective immune response against P. aeruginosa infection in vivo, and suggest that pharmacological interventions targeting the autophagy pathway could have considerable therapeutic potential in the treatment of P. aeruginosa lung infection. 相似文献
129.
130.
Michael L. Patnode Chu-Wen Cheng Chi-Chi Chou Mark S. Singer Matilda S. Elin Kenji Uchimura Paul R. Crocker Kay-Hooi Khoo Steven D. Rosen 《The Journal of biological chemistry》2013,288(37):26533-26545
Eosinophil accumulation is a characteristic feature of the immune response to parasitic worms and allergens. The cell surface carbohydrate-binding receptor Siglec-F is highly expressed on eosinophils and negatively regulates their accumulation during inflammation. Although endogenous ligands for Siglec-F have yet to be biochemically defined, binding studies using glycan arrays have implicated galactose 6-O-sulfate (Gal6S) as a partial recognition determinant for this receptor. Only two sulfotransferases are known to generate Gal6S, namely keratan sulfate galactose 6-O-sulfotransferase (KSGal6ST) and chondroitin 6-O-sulfotransferase 1 (C6ST-1). Here we use mice deficient in both KSGal6ST and C6ST-1 to determine whether these sulfotransferases are required for the generation of endogenous Siglec-F ligands. First, we characterize ligand expression on leukocyte populations and find that ligands are predominantly expressed on cell types also expressing Siglec-F, namely eosinophils, neutrophils, and alveolar macrophages. We also detect Siglec-F ligand activity in bronchoalveolar lavage fluid fractions containing polymeric secreted mucins, including MUC5B. Consistent with these observations, ligands in the lung increase dramatically during infection with the parasitic nematode, Nippostrongylus brasiliensis, which is known to induce eosinophil accumulation and mucus production. Surprisingly, Gal6S is undetectable in sialylated glycans from eosinophils and BAL fluid analyzed by mass spectrometry. Furthermore, none of the ligands we describe are diminished in mice lacking KSGal6ST and C6ST-1, indicating that neither of the known galactose 6-O-sulfotransferases is required for ligand synthesis. These results establish that ligands for Siglec-F are present on several cell types that are relevant during allergic lung inflammation and argue against the widely held view that Gal6S is critical for glycan recognition by this receptor. 相似文献